Relative contribution of dietary protein level and aflatoxin B1 dose in generation of presumptive preneoplastic foci in rat liver
- PMID: 3100852
Relative contribution of dietary protein level and aflatoxin B1 dose in generation of presumptive preneoplastic foci in rat liver
Abstract
Male weanling F344 rats were orally gavaged with aflatoxin B1 (AFB1) in daily doses of 200, 235, 270, 300, and 350 micrograms/kg/day for a total of 10 doses over a 12-day period, and then 1 week after the last dose they were fed diets of varying protein (casein) content to compare the contribution of AFB1 dose and dietary protein level on the development of presumptive preneoplastic gamma-glutamyltransferase-positive (GGT+) foci in rat liver. All animals were fed the same 20% dietary casein level during the dosing period. One week after the end of the dosing period, one-half of the animals in each dose group were then continued on the 20% casein diet for the entire 12-week foci-development period; the remaining half in each dose group were fed lower levels of dietary casein during the foci-development period for the increasing AFB1 dose groups (20, 16, 12, 8, and 4% casein for the 235-, 250-, 270-, 300-, and 350-micrograms/kg/day groups, respectively). The AFB1 dose groups used were determined in a preliminary experiment. In this previous experiment, a clearly discernible threshold dose at about 100-150 micrograms AFB1/kg/day (below which no GGT+ foci were observed) and a steep slope between 150 and 400 micrograms/kg/day were produced. In the second experiment, while the expected positive slope of (AFB1) dose versus (GGT+ foci) response relationship was found for animals fed the 20% casein diet, the dose response for the animals fed the lower levels of casein was eliminated, providing evidence that nutrient intake during the postdosing foci development is more rate limiting toward the development of these preneoplastic lesions than is the carcinogen dose.
Similar articles
-
Effect of high and low dietary protein on the dosing and postdosing periods of aflatoxin B1-induced hepatic preneoplastic lesion development in the rat.Cancer Res. 1983 May;43(5):2150-4. Cancer Res. 1983. PMID: 6131741
-
The sustained development of preneoplastic lesions depends on high protein intake.Nutr Cancer. 1992;18(2):131-42. doi: 10.1080/01635589209514213. Nutr Cancer. 1992. PMID: 1359506
-
Dietary protein intervention during the postdosing phase of aflatoxin B1-induced hepatic preneoplastic lesion development.J Natl Cancer Inst. 1983 Mar;70(3):547-9. J Natl Cancer Inst. 1983. PMID: 6132019
-
Thermogenesis, low-protein diets, and decreased development of AFB1-induced preneoplastic foci in rat liver.Nutr Cancer. 1991;16(1):31-41. doi: 10.1080/01635589109514138. Nutr Cancer. 1991. PMID: 1681520
-
Dietary protein level and aflatoxin B1-induced preneoplastic hepatic lesions in the rat.J Nutr. 1987 Jul;117(7):1298-302. doi: 10.1093/jn/117.7.1298. J Nutr. 1987. PMID: 2886567
Cited by
-
Cancer Prevention and Treatment by Wholistic Nutrition.J Nat Sci. 2017 Oct;3(10):e448. J Nat Sci. 2017. PMID: 29057328 Free PMC article.
-
Nutritional Renaissance and Public Health Policy.J Nutr Biol. 2017;3(1):124-138. doi: 10.18314/jnb.v3i1.145. Epub 2017 Aug 25. J Nutr Biol. 2017. PMID: 29177204 Free PMC article.
-
Efficacy of probiotic, prebiotic, and synbiotics supplements in individuals with anemia: a systematic review and meta-analysis of randomized controlled trials.BMC Gastroenterol. 2024 Dec 23;24(1):472. doi: 10.1186/s12876-024-03562-8. BMC Gastroenterol. 2024. PMID: 39716076 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Miscellaneous